Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

GRAND RAPIDS, Mich. — Just a few hours into the trial of Christopher Schurr, jurors have already heard from several people who saw firsthand the struggle that ended in a fatal shot to Patrick ...

Clinical trials provide access to novel treatments, comprehensive care, and closer monitoring, improving outcomes for GI cancer patients. Multidisciplinary planning and biomarker testing are crucial ...

For kidney transplant recipient Janet Handal, the recent push to phase out COVID-19 research could have a deadly outcome. In early 2021, Handal participated in a study that found almost half of ...

Clinical trials allow doctors and researchers to evaluate the effectiveness and safety of various medical treatments. A person with a greater chance of developing a specific condition who meets ...

There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained. There are a number of reasons why patients with cancer are ...

Clinical trials offer a unique treatment experience when you live with myeloproliferative disorders. Lower cost of care, direct access to a specialized MDS medical team, and the opportunity to try ...

Both roles will be key operational leaders for the school’s clinical trials administration, developing standard operating procedures, streamlining workflow processes, and ensuring adherence to ...

Spokespeople for Eli Lilly, Bristol Myers Squibb, Sanofi and Roche’s Genentech confirmed in emails to Fierce Biotech that their work on advancing clinical trial diversity remains ongoing.

More information: Unlu, O et al. Manual vs. AI-Assisted Prescreening for Trial Eligibility Using Large Language Models— A Randomized Clinical Trial, JAMA (2025). DOI: 10.1001/jama.2024.28047 ...

By Stephanie Nolen Stephanie Nolen has reported on U.S.A.I.D.-funded clinical trials in more than a dozen countries in Africa, Asia and Latin America. Feb. 6, 2025 Asanda Zondi received a ...

A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The announcement comes as artificial ...